UroGen Pharma Ltd (LTS:0XOD)
$ 38.6 -2.27 (-5.55%) Market Cap: 1.86 Bil Enterprise Value: 1.92 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 52/100

Q1 2026 Urogen Pharma Ltd Earnings Call Transcript

May 6, 2026 / 02:00 PM GMT
Release Date Price: $27.15 (+16.55%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

URGN.OQ - Urogen Pharma Ltd
Q1 2026 Urogen Pharma Ltd Earnings Call
May 06, 2026 / 02:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day and thank you for standing by. Welcome to the Eurogen Pharma.

Q1 2026 Results Earning Call.

At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session.

To ask a question during the session, you will need to press *11 on your telephone. You will then hear an automated message advising your hand is raised.

To withdraw your question, please press *11 again.

Please be advised that today's conference call is being recorded.

I would now like to hand the conference over to your first speaker today, Vincent Perrone, Senior Director of IR.

-----------------------------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot